Organization
Imagine Institute
1 clinical trial
Clinical trial
Phase 2 Study of Brentuximab Vedotin Associated With CHP Followed by Consolidation With High-dose Therapy / Autologous Stem-cell Transplantation as Frontline Treatment of Patients With Enteropathy-associated T-cell Lymphoma Type 1.Status: Completed, Estimated PCD: 2022-11-21